Compare Bio Protocol (BIO) vs eCash (XEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs eCash — how do they compare? Bio Protocol trades at Rp492.57 (market cap Rp1,1T, Rp300,52M 24h volume), while eCash trades at Rp0.1223 (market cap Rp2,46T, Rp2,17T 24h volume). The key difference: eCash is far larger — about 2.2× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 20,1T / 21T XEC (96%) for eCash. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and eCash for 116 Days on average.
| BIO | XEC | |
|---|---|---|
Market Cap | Rp1,1T | Rp2,46T |
Volume (24h) | Rp300,52M | Rp2,17T |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 20,1T / 21T XEC (96%) |
Typical Hold Time | 16 Days | 116 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
eCash (XEC) is trading at Rp0.12184 with a market cap of Rp2.44T, showing bearish technical signals with 15 sell indicators versus 4 buy signals. The token is near full circulation at 96% with an average hold time of 116 days. Recent technical analysis indicates oversold conditions with RSI_6 at 21.11, suggesting potential for short-term recovery despite the dominant bearish trend.
Overall outlook remains cautious with technical weakness but potential oversold bounce opportunities. Major risks include high volatility and limited fundamental developments, while the near-complete token distribution provides some supply stability. Investors should monitor for any protocol updates or exchange listing developments that could impact liquidity.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About eCash
ECash (XEC) is the rebranded version of Bitcoin Cash ABC (BCHA), itself a fork of Bitcoin (BTC) and Bitcoin Cash (BCH). It calls itself a "cryptocurrency that's designed to be used as electronic cash." ECash strictly aims to be a means of transaction used to pay for goods and services.
Read more on XEC →
